Research.Patient.info
Post Covid Syndrome (PCS) research hub
2 indexed studies · 1 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
Randomized adaptive assessment of post COVID syndrome treatments (RAPID) Reducing Inflammatory Activity in Patients with post COVID Syndrome (REVIVE)
This study, called REVIVE, is looking at new ways to treat Post-COVID Syndrome (long COVID). It will test different doses of a medicine called IMU-838 to see if it helps improve physical abilities in people still experiencing symptoms after having COVID.
Germany - authorisedTherapeutic exploratory (Phase II)
Randomized adaptive assessment of post COVID syndrome treatments (RAPID): Evaluating the Efficacy of Bupropion for the Treatment of Post-COVID-19 Syndrome-associated Fatigue (ELAPSE)
This study looks at treating long-term tiredness (fatigue) and physical difficulties after having COVID-19. It compares a drug called Bupropion with a dummy pill (placebo) to see if it helps people feel better and improve their daily activities.
Germany